These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

399 related articles for article (PubMed ID: 23071355)

  • 1. Targeting cancer metabolism.
    Teicher BA; Linehan WM; Helman LJ
    Clin Cancer Res; 2012 Oct; 18(20):5537-45. PubMed ID: 23071355
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isocitrate dehydrogenase (IDH), succinate dehydrogenase (SDH), fumarate hydratase (FH): three players for one phenotype in cancer?
    Laurenti G; Tennant DA
    Biochem Soc Trans; 2016 Aug; 44(4):1111-6. PubMed ID: 27528759
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of metabolic enzymes in mesenchymal tumors and tumor syndromes: genetics, pathology, and molecular mechanisms.
    Schaefer IM; Hornick JL; Bovée JVMG
    Lab Invest; 2018 Apr; 98(4):414-426. PubMed ID: 29339836
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic alteration in tumorigenesis.
    Yang H; Xiong Y; Guan K
    Sci China Life Sci; 2013 Dec; 56(12):1067-75. PubMed ID: 24114443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gerometabolites: the pseudohypoxic aging side of cancer oncometabolites.
    Menendez JA; Alarcón T; Joven J
    Cell Cycle; 2014; 13(5):699-709. PubMed ID: 24526120
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetically-defined metabolic reprogramming in cancer.
    Mullen AR; DeBerardinis RJ
    Trends Endocrinol Metab; 2012 Nov; 23(11):552-9. PubMed ID: 22858391
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inborn and acquired metabolic defects in cancer.
    Frezza C; Pollard PJ; Gottlieb E
    J Mol Med (Berl); 2011 Mar; 89(3):213-20. PubMed ID: 21301796
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of mutation of metabolism-related genes in genomic hypermethylation.
    Waterfall JJ; Killian JK; Meltzer PS
    Biochem Biophys Res Commun; 2014 Dec; 455(1-2):16-23. PubMed ID: 25111818
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The functional roles of TCA cycle metabolites in cancer.
    Eniafe J; Jiang S
    Oncogene; 2021 May; 40(19):3351-3363. PubMed ID: 33864000
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Revisiting the TCA cycle: signaling to tumor formation.
    Raimundo N; Baysal BE; Shadel GS
    Trends Mol Med; 2011 Nov; 17(11):641-9. PubMed ID: 21764377
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic enzymes as oncogenes or tumor suppressors.
    Thompson CB
    N Engl J Med; 2009 Feb; 360(8):813-5. PubMed ID: 19228626
    [No Abstract]   [Full Text] [Related]  

  • 12. Mitochondrial dysfunctions in cancer: genetic defects and oncogenic signaling impinging on TCA cycle activity.
    Desideri E; Vegliante R; Ciriolo MR
    Cancer Lett; 2015 Jan; 356(2 Pt A):217-23. PubMed ID: 24614286
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic reprogramming and epithelial-to-mesenchymal transition in cancer.
    Sciacovelli M; Frezza C
    FEBS J; 2017 Oct; 284(19):3132-3144. PubMed ID: 28444969
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Succinate dehydrogenase and fumarate hydratase: linking mitochondrial dysfunction and cancer.
    King A; Selak MA; Gottlieb E
    Oncogene; 2006 Aug; 25(34):4675-82. PubMed ID: 16892081
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The metabolic alterations of cancer cells.
    Sciacovelli M; Gaude E; Hilvo M; Frezza C
    Methods Enzymol; 2014; 542():1-23. PubMed ID: 24862258
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fumarate hydratase in cancer: A multifaceted tumour suppressor.
    Schmidt C; Sciacovelli M; Frezza C
    Semin Cell Dev Biol; 2020 Feb; 98():15-25. PubMed ID: 31085323
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cancer. Puzzling patterns of predisposition.
    Pollard PJ; Ratcliffe PJ
    Science; 2009 Apr; 324(5924):192-4. PubMed ID: 19359573
    [No Abstract]   [Full Text] [Related]  

  • 18. Metabolic Enzymes in Sarcomagenesis: Progress Toward Biology and Therapy.
    Li L; Eid JE; Paz AC; Trent JC
    BioDrugs; 2017 Oct; 31(5):379-392. PubMed ID: 28840584
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isocitrate dehydrogenase 1 and 2 mutations in cancer: alterations at a crossroads of cellular metabolism.
    Reitman ZJ; Yan H
    J Natl Cancer Inst; 2010 Jul; 102(13):932-41. PubMed ID: 20513808
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aerobic glycolysis: a novel target in kidney cancer.
    Shuch B; Linehan WM; Srinivasan R
    Expert Rev Anticancer Ther; 2013 Jun; 13(6):711-9. PubMed ID: 23773105
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.